S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA

• K Ohene-Frempong,
• C Segbefia,
• J Spector,
• E Amoah,
• A Asubonteng,
• R Hammond-Addo,
• I Odame,
• I Odame

Affiliations

K Ohene-Frempong

1 Sickle Cell Foundation of Ghana, Accra, GHANA

C Segbefia

2 Department of Child Health, University of Ghana Medical School, Accra, Ghana, Accra, GHANA

J Spector

3 Novartis Institutes for Biomedical Research, Cambridge, MA, UNITED STATES

E Amoah

1 Sickle Cell Foundation of Ghana, Accra, GHANA

A Asubonteng

1 Sickle Cell Foundation of Ghana, Accra, GHANA

R Hammond-Addo

4 Novartis Corporate Affairs & Global Health, Accra, GHANA

I Odame

5 Departments of Medicine and Paediatrics, University of Toronto, Toronto, CANADA

I Odame

5 Departments of Medicine and Paediatrics, University of Toronto, Toronto, CANADA